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Abstract
BACKGROUND: Leukemia is a blood malignancy that has a variety of types with a variety of clinical manifestations 
in the body organs in each patient. Acute myeloblastic leukemia (AML) occurs more frequently in adults with clinical 
manifestations in the central nervous system, especially on the M4 and M5 subtypes.
CASE REPORT: A 42-year-old woman came with a complaint of sudden left hemiparesis. The laboratory results 
obtained leukocytosis, normochromic normocytic anemia, and thrombocytopenia. Peripheral blood smear found 
immature cells of the myeloblasts and monoblasts series and monocytosis.
CONCLUSION: The conclusion of the clinical diagnosis and laboratory of the patient is left hemiparesis caused by 
AML with the suspect of subtype M4 or M5. Patients died within a few hours later, so bone marrow puncture and brain 
fluid retrieval for malignant cell analysis could not be performed. Brain fluid analysis is important to be performed to 
enforce the diagnosis of cerebral leukemia.
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Introduction
Leukemia is one of the malignancies in 
which its incidence began to increase. This is due to 
the increasing number of risk factors triggering the 
occurrence of genetic mutation or imbalance between 
oncogenes and antioncogenes. One of the types of 
leukemia occurs from the myeloid pathway, better 
known as acute myeloblastic leukemia (AML) [1].
In 2010, this type of AML reached an incidence 
of 4.0 (in 100,000 residences) in the US, while in other 
developed countries such as Germany reached 5.2. 
This development concluded 35,000 new cancer cases 
per year. The mortality rate of AML in the US reached 
12,000 in 2015. The median age of the diagnosed AML 
was 67 years and there were no differences between 
males and females [2].
There are seven subtypes of AML based on the 
French American British (FAB) classification. The M3 
subtype in AML has the highest number of incidences, 
followed by the M2, M0, M4, and M1 subtypes. The 
other subtypes (M5, M6, and M7) have an incidence 
rate of less than 10%. The incidence of AML has 
various clinical manifestations and a broad spectrum 
of hematological cell profiles (low to high amounts), 
including hemoglobin, leukocytes, and platelets [2].
Clinical manifestations of AML may involve 
the central nervous system called cerebral leukemia 
which is fatal in patients. Manifestations of the central 
nervous system have a low prevalence at the time of 
diagnosing AML. A diagnostic strategy of complications 
and appropriate treatment is required for the situation. 
Here will be shown a case report of an AML patient 
with left hemiparesis as a complication in the central 
nervous system with high mortality [3], [4].
Patient and Observation
A 42-year-old woman came to the emergency 
unit with the main complaint of a sudden inability to 
move the left hand and leg. The patient went straight 
to the hospital that morning (at 9 a.m.). The patient 
also felt difficult to speak, slight fever, and dizziness 
along with the main complaint. She did not feel either 
nauseous or vomiting. Defecation and urination were 
within normal limits. The patient had a history of stroke 
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and underwent a routine follow-up to the neurologist. 
She had no previous history of diabetes mellitus and 
hypertension, but the patient claimed to have a history 
of high-fat laboratory results.
Patients seemed conscious in general and 
appeared weak with the blood pressure of 150/90 mmHg, 
pulsation rate of 90 times/min, respiratory rate of 
20 times/min, and temperature of 37.6°C. The eye 
examination obtained by mild anemic conjunctiva and 
there was no icteric sclera. The neurology examination 
of the face found no abnormalities on the right side either 
on the forehead, palpebral, tongue, and lips. There 
were no abnormalities and bleeding from the nose, 
mouth, nor the ears. Cardiac and lung examinations 
were within normal limits. The abdominal examination 
did not find organomegaly or tenderness. There was 
no lymphadenopathy in the lymph glands. There was 
decreased muscle strength in the left upper and lower 
extremities compared to the right extremities. The 
physiological reflex examination on the left side of the 
body increased as well as pathological reflexes, while 
the right side of the body found normal physiological 
reflexes and negative pathological reflexes.
Laboratory examination obtained a hemoglobin 
level of 10 g/dL comparable to the decreased hematocrit 
level, a corresponding number of erythrocytes to the 
hemoglobin, normal MCV, and MCH levels, indicating 
normochromic normocytic anemia. It also found 
thrombocytopenia with a platelet count of 130,000/
μl. There was an increased number of leukocytes of 
78.000/μl. The patient’s laboratory examination results 
were summarized in Table 1.
Table 1: The complete result of laboratory examination of the 
patient
Parameter (values) Laboratory results
Hematological parameters
Hb (g/dL) 10.0
Hct (%) 32.0
Erythrocyte number (×106/µl) 3.4
MCV (Fl) 93.2
MCH (Pg) 29.3
MCHC (%) 30.5
Leukocyte number (×103/µl) 78
Platelet number (×103/µl) 130
Clinical chemistry
Random blood glucose (mg/dL) 350
AST (IU/L) 43
ALT (IU/L) 35
Ureum (mg/dL) 25
Creatinine (mg/dL) 1.1
The peripheral blood morphology obtained 
normochromic normocytic anemia. The estimated 
number of leukocytes increased with the appearance 
of blast cells of 13%, AMC of 20%, neutropenia, and 
monocytosis as well as giant lysosomes (Figure 1). It 
also found a decreased estimated number of platelets 
with large platelet size.
The patient has been declared stable with 
monitoring in the emergency room while waiting for 
the head CT-scan in the referral hospital. The patient 
experienced a sudden loss of consciousness at 2.45 p.m. 
and underwent cardiac pulmonary resuscitation. The 
patient was declared dead at 3 p.m. in the emergency 
room. There was not enough time for performing bone 
marrow puncture to establish the definite diagnosis of 
the hematological malignancy.
Discussion
The patient came with symptoms and clinical 
signs of lateralization, leading to a diagnosis of 
stroke. Complete blood count examination showed 
bicytopenia (normochromic normocytic anemia and 
thrombocytopenia) and leukocytosis. The peripheral 
blood smear showed normochromic normocytic anemia, 
thrombocytopenia, and blasts cells (myeloblasts 
and monoblasts) accompanied by neutropenia and 
monocytosis. Clinical chemistry examination showed 
normal liver and kidney function and hyperglycemia.
The diagnosis was established based on 
clinical findings of left hemiparesis and laboratory 
results, suspecting cerebral leukemia caused by 
suspected AML. The patient also experienced reactive 
hyperglycemia with a differential diagnosis of Type 
Figure 1: Cells found in peripheral blood smear. Explanation: (a-c) 
Monoblast; (d) myeloblasts; (e) myeloblast with giant lysosome 
(arrow)
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2 diabetes mellitus. The patient underwent a routine 
follow-up to the neurologist due to her previous history 
of stroke. However, the history of her complete blood 
count was within normal limit and indicated no such 
condition. The state of hyperglycemia in the patient was 
suspected reaction of an acute inflammatory condition 
and the patient claimed to have no prior diabetes 
mellitus history; however, the differential diagnosis of 
Type 2 diabetes mellitus was taken for being evaluated 
subsequently.
The clinical course of acute leukemia is worse 
than chronic leukemia. Various symptoms can arise in 
acute leukemia patients that vary from each person. 
Some patients came with mild to severe symptoms; 
some others came with sudden or long-lasting 
symptoms. The symptoms and the clinical signs include 
lethargy, fever, decreased appetite, decreased weight, 
enlarged stomach, bleeding, visual disturbances, 
headaches, and others [5], [6].
Laboratory examination obtained in acute 
leukemia patients showed various results. In general, 
it showed leukocytosis accompanied by anemia 
with platelets. Some cases did not indicate such a 
condition but showing normal leukocytes, anemia, and 
thrombocytopenia. There were cases of leukemia with 
a normal state of blood cells called aleukemic leukemia. 
The results of the laboratory examination obtained 
should be adjusted to the patient’s clinical condition. 
The subsequent laboratory test carried out is the 
peripheral blood smear to perform screening and bone 
marrow puncture to establish the diagnosis of acute 
leukemia [5], [7], [8].
The peripheral blood smear was used for the 
evaluation of the patient’s cells, both for screening 
and diagnosing hematological disorders. Various cells 
can be found depending on the type of leukemia. 
Myeloblasts and lymphoblasts, as well as other 
immature cells from various maturation pathways of 
blood cells, can be found depending on the type and 
subtype of leukemia [7], [8]. Definite diagnosis was 
established by performing bone marrow puncture as 
well as bone marrow biopsy. The parameters of the 
results were the cellularity, the dominant cell types in 
the hematopoietic pathway underlying leukemia, and 
establishing the diagnosis of leukemia.
One of the acute leukemia types found is AML 
developing from the myeloid progenitor cells. According 
to the FAB classification, this type of leukemia is divided 
into eight subtypes from M0 to M7. Each subtype of 
AML has its distinguished characteristic based on the 
findings of immature cells and the development of 
the cells. This is the underlying diagnosis of the AML 
subtype.
In this case, the peripheral blood smear showed 
myeloblasts and monoblasts despite not performing 
the bone marrow puncture. This is the underlying 
diagnosis of the suspected AML of subtypes M4 and 
M5. Furthermore, the patient was showing a symptom 
of hemiparesis, which is a manifestation of leukemia 
cells in the central nervous system. This condition is 
supported by Stefano et al. (2005) [9] stated that the 
complications of AML to the central nervous system 
could occur in AML, mostly in M3 subtype followed 
by other subtypes such as M4, M5, and M1. Other 
authors suggested the same opinion. Manifestations 
of the central nervous system could be obstruction, 
bleeding, infection, and infarction. This condition 
could occur due to the hyperviscosity of blood, leading 
to the occlusion of the brain veins. Examination of 
cerebrospinal fluid analysis became important to 
establish the diagnosis of the complications called 
cerebral leukemia by discovering the presence of 
foreign or malignant cells [10].
Conclusion
The condition of acute leukemia, especially 
AML with a subtype of M4 and M5 known from the 
peripheral blood smear supported by the results of bone 
marrow puncture, required immediate LCS examination 
to establish the diagnosis of cerebral leukemia. This is 
done for the treatment of leukemia patients and lowering 
mortality in leukemia patients due to the abnormalities 
in the central nervous system.
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